Yewei Jia

410 total citations
19 papers, 291 citations indexed

About

Yewei Jia is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yewei Jia has authored 19 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yewei Jia's work include Bone Metabolism and Diseases (8 papers), Bone health and treatments (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yewei Jia is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Bone health and treatments (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yewei Jia collaborates with scholars based in China, Germany and Italy. Yewei Jia's co-authors include Yu Qian, Tan Zhang, Xuanyuan Lu, Weiqi Han, Wanlei Yang, Jiawei Jiang, An Qin, Peng Sun, Peng Sun and Cong Pang and has published in prestigious journals such as The FASEB Journal, Annals of the Rheumatic Diseases and Journal of Cellular Physiology.

In The Last Decade

Yewei Jia

18 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yewei Jia China 10 188 54 47 45 44 19 291
Christian Patry Germany 10 123 0.7× 30 0.6× 33 0.7× 61 1.4× 118 2.7× 25 333
S.H. Madsen Denmark 7 129 0.7× 60 1.1× 126 2.7× 65 1.4× 72 1.6× 12 387
Xifeng Xiong China 13 243 1.3× 128 2.4× 58 1.2× 38 0.8× 26 0.6× 29 399
Lydia Barré France 12 185 1.0× 36 0.7× 90 1.9× 54 1.2× 24 0.5× 17 368
Youqiang Sun China 8 242 1.3× 75 1.4× 45 1.0× 91 2.0× 26 0.6× 13 398
Ligang Jie China 11 211 1.1× 73 1.4× 117 2.5× 81 1.8× 28 0.6× 26 401
Kimberly J. Decker United States 6 204 1.1× 24 0.4× 28 0.6× 64 1.4× 26 0.6× 10 440
Yuangang Su China 14 391 2.1× 75 1.4× 44 0.9× 162 3.6× 75 1.7× 40 517
Hafedh Dekhil Canada 10 212 1.1× 37 0.7× 10 0.2× 86 1.9× 21 0.5× 13 387

Countries citing papers authored by Yewei Jia

Since Specialization
Citations

This map shows the geographic impact of Yewei Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yewei Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yewei Jia more than expected).

Fields of papers citing papers by Yewei Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yewei Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yewei Jia. The network helps show where Yewei Jia may publish in the future.

Co-authorship network of co-authors of Yewei Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Yewei Jia. A scholar is included among the top collaborators of Yewei Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yewei Jia. Yewei Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jia, Yewei, Rui Li, Yixuan Li, et al.. (2025). Melanoma bone metastasis-induced osteocyte ferroptosis via the HIF1α-HMOX1 axis. Bone Research. 13(1). 9–9. 5 indexed citations
2.
Jia, Yewei, Fulin Zhang, Darja Andreev, et al.. (2024). Osteocytes support bone metastasis of melanoma cells by CXCL5. Cancer Letters. 590. 216866–216866. 2 indexed citations
3.
Jiang, Jin, Yuqian Feng, Ying Zhao, et al.. (2024). Identification of KRT80 as a Novel Prognostic and Predictive Biomarker of Human Lung Adenocarcinoma via Bioinformatics Approaches. Combinatorial Chemistry & High Throughput Screening. 28(11). 1872–1887.
4.
Zhang, Wenshuo, Ning Liu, Iris Stolzer, et al.. (2024). Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery. Annals of the Rheumatic Diseases. 83(8). 984–997. 13 indexed citations
5.
Zheng, Yuanyuan, Wenjuan Yang, Yewei Jia, et al.. (2023). Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction. Frontiers in Pharmacology. 14. 1081980–1081980. 4 indexed citations
6.
Jiang, Jin, Yu Zhang, Jun Wang, et al.. (2023). Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches. PeerJ. 11. e16166–e16166. 3 indexed citations
7.
Yang, Qichang, Yewei Jia, Haibo Li, et al.. (2023). Morusin Inhibits RANKL-induced Osteoclastogenesis and OvariectomizedOsteoporosis. Combinatorial Chemistry & High Throughput Screening. 27(9). 1358–1370. 4 indexed citations
8.
Zhang, Wenshuo, et al.. (2022). Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma. Frontiers in Cell and Developmental Biology. 10. 974851–974851. 12 indexed citations
9.
Yang, Wanlei, Xuanyuan Lu, Tan Zhang, et al.. (2021). TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling. Bone Research. 9(1). 33–33. 42 indexed citations
10.
Zhang, Tan, Qichang Yang, Yewei Jia, et al.. (2021). Galangin attenuates IL-1β-induced catabolism in mouse chondrocytes and ameliorates murine osteoarthritis.. American Journal of Translational Research. 13(8). 8742–8753. 2 indexed citations
11.
Zhang, Tan, Lei He, Wanlei Yang, et al.. (2020). Byakangelicin inhibits IL-1β–induced mouse chondrocyte inflammation in vitro and ameliorates murine osteoarthritis in vivo. International Immunopharmacology. 85. 106605–106605. 12 indexed citations
12.
Sun, Peng, Qichang Yang, Yewei Jia, et al.. (2020). <p>Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo</p>. Drug Design Development and Therapy. Volume 14. 4189–4203. 5 indexed citations
13.
Jia, Yewei, Wei He, Hanxiao Zhang, et al.. (2020). <p>Morusin Ameliorates IL-1β-Induced Chondrocyte Inflammation and Osteoarthritis via NF-κB Signal Pathway</p>. Drug Design Development and Therapy. Volume 14. 1227–1240. 40 indexed citations
14.
Jia, Yewei, Cong Pang, Jiawei Jiang, et al.. (2019). Garcinol Suppresses IL-1β-Induced Chondrocyte Inflammation and Osteoarthritis via Inhibition of the NF-κB Signaling Pathway. Inflammation. 42(5). 1754–1766. 37 indexed citations
15.
Jia, Yewei, Tan Zhang, Weiqi Han, et al.. (2019). Anacardic acid inhibits RANKL‐induced osteoclastogenesis in vitro and prevents ovariectomy‐induced bone loss in vivo. The FASEB Journal. 33(8). 9100–9115. 17 indexed citations
16.
Jia, Yewei, Jiawei Jiang, Tan Zhang, et al.. (2019). Disulfiram suppressed ethanol promoted RANKL-induced osteoclastogenesis in vitro and ethanol-induced osteoporosis in vivo via ALDH1A1-NFATc1 axis. Aging. 11(19). 8103–8119. 6 indexed citations
17.
Zhang, Tan, Weiqi Han, Wanlei Yang, et al.. (2019). Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts. The FASEB Journal. 33(4). 5399–5410. 52 indexed citations
18.
Jiang, Jiawei, et al.. (2019). Vitexin suppresses RANKL‐induced osteoclastogenesis and prevents lipopolysaccharide (LPS)‐induced osteolysis. Journal of Cellular Physiology. 234(10). 17549–17560. 17 indexed citations
19.
Jia, Yewei, Jiawei Jiang, Xuanyuan Lu, et al.. (2018). Garcinol suppresses RANKL‐induced osteoclastogenesis and its underlying mechanism. Journal of Cellular Physiology. 234(5). 7498–7509. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Patry Breakdown of academic impact, for papers by S.H. Madsen Breakdown of academic impact, for papers by Xifeng Xiong Breakdown of academic impact, for papers by Lydia Barré Breakdown of academic impact, for papers by Youqiang Sun Breakdown of academic impact, for papers by Ligang Jie Breakdown of academic impact, for papers by Kimberly J. Decker Breakdown of academic impact, for papers by Yuangang Su Breakdown of academic impact, for papers by Hafedh Dekhil
Rankless by CCL
2026